Literature DB >> 825578

Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming.

M J Bevan.   

Abstract

The cellular basis of the cross-priming observed with minor histocompatibility antigens on H-2 different cells was investigated. Cytotoxic T cells induced against minor alloantigens show absolute H-2 restriction at the effector level ([51Cr]-release). That is, F1 (BALB/c X BALB.B) (H-2d/b) cytotoxic cells induced by immunization with B10(H-2b) cells are not able to lyse B10.D2(H-2d) targets. But an injection of B10 cells does prime F1 mice for a secondary cytotoxic response to B10.D2. The technique of inducing cytotoxic effector function polyclonally with Con A in the absence of alloantigen was used here to establish that such cross-priming reflects what happens at the cytotoxic cell level. It is shown that an F1 animal previously injected with B10 cells has expanded pools of memory cytotoxic cells reactive with B10 and B10.D2. From this it is concluded that: a) minor H structures on B10.D2 and B10 do cross-react at the cytotoxic T cell level during in vivo priming, and b) because normal cells cross-prime whereas tumor cells do not, then the F1 cytotoxic precursors are probably committed to respond to antigen on cells bearing either the maternal or paternal H-2 haplotype before they encounter antigen. Cross-priming may be explained by foreign minor H antigens being presented to F1 host T cells on the surface of host macrophages. Therefore priming is not restricted to the H-2 type of the injected cells but to both H-2 types of the F1 host.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

Review 1.  Heat shock proteins: the fountainhead of innate and adaptive immune responses.

Authors:  S Basu; P K Srivastava
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

Review 2.  The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells.

Authors:  H Singh-Jasuja; N Hilf; H U Scherer; D Arnold-Schild; H G Rammensee; R E Toes; H Schild
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

3.  Heat-aggregated noninfectious influenza virus induces a more balanced CD8(+)-T-lymphocyte immunodominance hierarchy than infectious virus.

Authors:  Yunjung Cho; Sameh Basta; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 4.  Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

Authors:  Sven Brode; Paul A Macary
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

5.  Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses.

Authors:  Yoshikazu Honda-Okubo; Fadi Saade; Nikolai Petrovsky
Journal:  Vaccine       Date:  2012-06-20       Impact factor: 3.641

Review 6.  CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity.

Authors:  G Elizabeth Pluhar; Christopher A Pennell; Michael R Olin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

7.  Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants.

Authors:  Daniel Chargelegue; Pascal M W Drake; Patricia Obregon; Alessandra Prada; Neil Fairweather; Julian K-C Ma
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 8.  DNA vaccines against human immunodeficiency virus type 1 in the past decade.

Authors:  Malavika Giri; Kenneth E Ugen; David B Weiner
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Oxidized lipids block antigen cross-presentation by dendritic cells in cancer.

Authors:  Rupal Ramakrishnan; Vladimir A Tyurin; Vladimir A Tuyrin; Filippo Veglia; Thomas Condamine; Andrew Amoscato; Dariush Mohammadyani; Joseph J Johnson; Lan Min Zhang; Judith Klein-Seetharaman; Esteban Celis; Valerian E Kagan; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2014-02-19       Impact factor: 5.422

10.  Major histocompatibility complex restriction of T-cell responses to varicella-zoster virus in guinea pigs.

Authors:  A R Hayward; R Burger; R Scheper; A M Arvin
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.